MOTS-c 10mg (Mitochondrial-derived Peptide)
Size: 10mg | 99% Purity
M.Wt: 2174.56
Solubility: H2O
Purity: >99%
Storage: -20°C / 3 years
Half life: Not established
CAS No.: 1627580-64-6
| Purity (HPLC) | >99% |
|---|---|
| Molecular weight | 2174.56 g/mol |
| CAS number | 1627580-64-6 |
| Synonyms | MOTS-c, Mitochondrial ORF of the 12S rRNA type-c |
| Solubility | H2O |
| Storage | -20°C / 3 years |
★ Bestseller
Only 6 left in stock
Research reference: View mechanism, literature and identifier graph →
Reconstitution calculator (pre-filled for 10 mg)
HPLC and MS verified by UKAS-accredited laboratories.
Royal Mail 24 and DPD Next Day options.
COA and batch number on every vial.
Description
Size: 10mg | 99% Purity
M.Wt: 2174.56
Solubility: H2O
Purity: >99%
Storage: -20°C / 3 years
Half life: Not established
CAS No.: 1627580-64-6
*(This is a lyophilised powder and will need reconstitution — We also supply Sterile Water for Reconstitution separately.)
Reconstitution
For peptides supplied as lyophilised powder, reconstitute in bacteriostatic water or sterile saline at the concentration appropriate to your protocol. Allow the vial to come to room temperature before opening, add solvent slowly down the inside wall (do not directly onto the powder), and gently invert until clear. Do not vortex.
Reconstituted solutions are typically stable at 2–8°C for the durations published in the corresponding peer-reviewed reference. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze–thaw cycles.
Research literature
Selected peer-reviewed publications from PubMed referencing this compound. Provided for research orientation — not an endorsement of any clinical application. Each citation links to the canonical PubMed record.
-
MOTS-c Functionally Prevents Metabolic Disorders.
Gao Y et al. · Metabolites · 2023
PubMed PMID 36677050 -
MOTS-c reduces myostatin and muscle atrophy signaling.
Kumagai H et al. · American journal of physiology. Endocrinology and metabolism · 2021
PubMed PMID 33554779 -
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.
Zheng Y et al. · Frontiers in endocrinology · 2023
PubMed PMID 36761202
You may also need
Related compounds
